semaglutide trials near me Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity Blockbuster GLP-1 Diabetes and Weight
Description
Conclusion In conclusion, semaglutide is a highly effective medication for weight loss, benefiting both diabetic and non-diabetic patients
Indirectly from our clients or their agents
Last medically reviewed: May 2026 Find the right provider for your needs select your state to find expert care near you.
The FDA gave compounders until May to wind down
doi: 10.1016/S0140-6736(08)61246-5
